HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO) reported fourth-quarter results that fell short of analyst ...

Inc. (NYSE: BIO and BIO.B), a $8.49 billion market cap company known for its life science research and clinical diagnostics products, has announced plans to acquire Stilla Technologies, a developer of ...

Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...

加利福尼亚州赫丘利斯市 - 市值84.9亿美元的Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B)宣布计划收购下一代数字PCR解决方案开发商Stilla ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to ...

There are many symptoms that are common to a wide variety of diseases, like fever, which can indicate an infection, autoimmune disease, or ... | Clinical And Molecular Dx ...

Mold contamination of cannabis sold in Massachusetts is far more common than state regulators have acknowledged, according to some labs tasked with testing the products.

A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown origin in sub-Saharan Africa. Scientists examined 550 patients from Guinea who ...

A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown ...

Tick-borne encephalitis virus (TBEV) has now been confirmed in locally acquired human cases in the U.K., with evidence of ...